234 related articles for article (PubMed ID: 27939820)
1. Colistin-resistant Enterobacteriaceae infections: clinical and molecular characterization and analysis of in vitro synergy.
de Maio Carrillho CM; Gaudereto JJ; Martins RC; de Castro Lima VA; de Oliveira LM; Urbano MR; Perozin JS; Levin AS; Costa SF
Diagn Microbiol Infect Dis; 2017 Mar; 87(3):253-257. PubMed ID: 27939820
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome.
de Maio Carrilho CM; de Oliveira LM; Gaudereto J; Perozin JS; Urbano MR; Camargo CH; Grion CM; Levin AS; Costa SF
BMC Infect Dis; 2016 Nov; 16(1):629. PubMed ID: 27809803
[TBL] [Abstract][Full Text] [Related]
3. Low Frequency of Ceftazidime-Avibactam Resistance among Enterobacteriaceae Isolates Carrying
Castanheira M; Mendes RE; Sader HS
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031200
[No Abstract] [Full Text] [Related]
4. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae.
Berçot B; Poirel L; Dortet L; Nordmann P
J Antimicrob Chemother; 2011 Oct; 66(10):2295-7. PubMed ID: 21807739
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
[TBL] [Abstract][Full Text] [Related]
7. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
[TBL] [Abstract][Full Text] [Related]
8. Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.
Ku K; Pogue JM; Moshos J; Bheemreddy S; Wang Y; Bhargava A; Campbell M; Khandker N; Lephart PR; Chopra T; Hayakawa K; Martin ET; Abreu-Lanfranco O; Dhar S; Kaye KS; Marchaim D
Am J Infect Control; 2012 Dec; 40(10):983-7. PubMed ID: 22440526
[TBL] [Abstract][Full Text] [Related]
9. Combination Therapy against Polymicrobial Infection, Including by NDM-1-Producing Enterobacteriaceae Resistant to Colistin.
Nakamura I; Sakamoto N; Ida Y; Imai R; Aoki K; Ando R; Yamaguchi T; Matsumura H; Matsumoto T
Antimicrob Agents Chemother; 2015 Aug; 59(8):5092-3. PubMed ID: 26033729
[No Abstract] [Full Text] [Related]
10. Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant
Amladi AU; Abirami B; Devi SM; Sudarsanam TD; Kandasamy S; Kekre N; Veeraraghavan B; Sahni RD
Indian J Med Res; 2019 Feb; 149(2):185-191. PubMed ID: 31219082
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae.
Betts JW; Phee LM; Hornsey M; Woodford N; Wareham DW
Antimicrob Agents Chemother; 2014 Jun; 58(6):3541-6. PubMed ID: 24687491
[TBL] [Abstract][Full Text] [Related]
12. Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).
Sader HS; Castanheira M; Flamm RK; Mendes RE; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2015 Oct; 83(2):183-6. PubMed ID: 26164275
[TBL] [Abstract][Full Text] [Related]
13. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
[TBL] [Abstract][Full Text] [Related]
14. Over-treatment of carbapenemase-producing Enterobacteriaceae.
Rihani DS; Wallace MR; Sieger BE; Waite RA; Fox M; Brown SA; Deryke CA
Scand J Infect Dis; 2012 May; 44(5):325-9. PubMed ID: 22200121
[TBL] [Abstract][Full Text] [Related]
15. In-vitro susceptibility to colistin and tigecycline in New Delhi metallo-beta-lactamase-1 producing Enterobacteriaceae.
Chandran SP; Nagaraj S; Kalal BS; Muralidharan S; Macaden R
Indian J Med Microbiol; 2013; 31(4):419-20. PubMed ID: 24064660
[No Abstract] [Full Text] [Related]
16. Options for treating carbapenem-resistant Enterobacteriaceae.
Rafailidis PI; Falagas ME
Curr Opin Infect Dis; 2014 Dec; 27(6):479-83. PubMed ID: 25259809
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibilities of clinical isolates of carbapenemase-producing Enterobacteriaceae to fosfomycin and tigecycline.
Choudhury S; Yeng JL; Krishnan PU
Clin Microbiol Infect; 2015 Oct; 21(10):e75-6. PubMed ID: 26086572
[No Abstract] [Full Text] [Related]
18. Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant
Yu L; Zhang J; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Li C; Zhang X
Front Cell Infect Microbiol; 2019; 9():422. PubMed ID: 31921701
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
[TBL] [Abstract][Full Text] [Related]
20. Activity of Tigecycline in combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-producing Enterobacteriaceae in a murine thigh infection model.
Michail G; Labrou M; Pitiriga V; Manousaka S; Sakellaridis N; Tsakris A; Pournaras S
Antimicrob Agents Chemother; 2013 Dec; 57(12):6028-33. PubMed ID: 24060874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
